Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
64.108,90
0,34%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Humacyte Inc (HUMA) Humacyte Inc (HUMA) Notizie

Humacyte Inc

HUMA
4,45
0,05 (1,14%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/3/202422:03EDGAR2Form SC 13D/A - General statement of acquisition of..
04/3/202412:53EDGAR2Form 8-K - Current report
29/2/202422:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202422:02EDGAR2Form 8-K - Current report
09/2/202414:06EDGAR2Form 8-K - Current report
12/12/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202314:06EDGAR2Form 8-K - Current report
09/11/202322:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:07EDGAR2Form 8-K - Current report
10/10/202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202322:09EDGAR2Form SC 13D/A - General statement of acquisition of..
15/9/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202313:09EDGAR2Form 8-K - Current report
12/9/202302:03DJNStocks to Watch: Oracle, Acelyrin, Humacyte
22/8/202300:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202300:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202300:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202322:28EDGAR2Form 144 - Report of proposed sale of securities
14/8/202314:44EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202313:05EDGAR2Form 8-K - Current report
31/7/202319:28DJNHumacyte Shares Rise 8% After Completing Enrollment in Phase..
26/7/202314:07EDGAR2Form 8-K - Current report
Apertura: 4,50 Min: 4,36 Max: 4,57
Chiusura: 4,40

La tua Cronologia

NASDAQ
HUMA
Humacyte
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network